Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
3,673,597
-
Share change
-
-531,069
-
Total reported value
-
$280,172,006
-
Price per share
-
$76.25
-
Number of holders
-
21
-
Value change
-
-$40,490,016
-
Number of buys
-
8
-
Number of sells
-
5
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2023
As of 31 Dec 2023,
Edwards Lifesciences Corp - Common Stock (EW) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,673,597 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, ALLIANCEBERNSTEIN L.P., BROWN ADVISORY INC, Bank of New York Mellon Corp, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, Capital International Investors, and NORGES BANK.
This page lists
1,236
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.